Susanne Saussele

24PUBLICATIONS
100CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

|Feb 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Michael Lauseker, Tomasz Sacha, Hana Klamova

|Jan 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

Andreas Burchert, Franck E Nicolini, Philipp le Coutre

|Dec 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective.

Philipp Ernst, Cera Lohse, Michael Lauseker

|Jul 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross

|May 07, 2025
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.

Michael J Mauro, Yosuke Minami, Andreas Hochhaus

Pageof 4

Frequent Collaborators

11 joint publications

Andreas Hochhaus

8 joint publications

Johan Richter

7 joint publications

Markus Pfirrmann

6 joint publications

Thomas Ernst